A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …

Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) as a strategy to stay competitive …

There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …

In the domain of drug discovery, there can be a world of difference between a computer-generated hit compound, which is …